Malaria

GSK's thirst for adjuvants grows

GSK's thirst for adjuvants grows

By Gregory Roumeliotis

GlaxoSmithKline (GSK) has asked vaccine developing firm Antigenics
to supply it with more of its QS-21 adjuvant as its vaccines
progress in the pipeline, while at the same the British drug giant
is pushing ahead with its own adjuvant,...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers